This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
HBSP (USA)
-
Merck: La administración de Vioxx (D)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCase HBS-111S05Knowledge and CommunicationStarting at €5.74
-
Merck: La administración de Vioxx (G)
Simons, Robert L.; Kindred, NatalieCase HBS-111S08Knowledge and CommunicationStarting at €8.20
-
Making the Numbers (Spanish version)
Simons, Robert L.; Packard, JenniferCase HBS-118S02Strategy1) founding, 2) growth, 3) push to profitability, 4) relocation process, and 5) takeover by new management. At each stage, students must confront tensions in balancing profit, growth and control. Difficulties encountered in the business are due to management's attempts to design and use formal control systems to achieve profit and performance goals.Starting at €8.20
-
ATH Technologies (A): cumpliendo los objetivos
Simons, Robert L.; Packard, JenniferCase HBS-118S03StrategyUn ejercicio que lleva a los estudiantes a través de cinco etapas de crecimiento empresarial en una puesta en marcha en la industria de dispositivos médicos: 1) fundación, 2) el crecimiento, 3) empuje a la rentabilidad, el proceso de reorientación 4) y 5) toma de control por la nueva administración. En cada etapa, los estudiantes deben hacer frente a las tensiones en el equilibrio de beneficios, el crecimiento y el control. Las dificultades encon...Starting at €8.20
-
Managing Risk in the New World
Kaplan, Robert S.; Mikes, Anette; Simons, Robert L.; Tufano, Peter; Hofmann, Michael; Champion, DavidArticle HBS-R0910E-EFive experts gathered recently to discuss the future of enterprise risk management: Kaplan, the Baker Foundation Professor at Harvard Business School, who with his colleague David Norton developed the balanced scorecard; Mikes, an assistant professor at HBS who studies the evolution of risk management and the role of the chief risk officer; Simons, the Charles M. Williams Professor of Business Administration at HBS; Tufano, the Sylvan C . Coleman...Starting at €8.20
-
Shenzhen Capital Group
Gompers, Paul A.; Chen, Shaohui; Lin, Jessie; Ling, ShelleyCase HBS-211029-EFinanceHaitao Jin, Chairman of Shenzhen Capital Group Co., Ltd. ("SCGC") and Wanshou Li, President of the SCGC must decide how to continue to grow their venture capital/private equity firm in China. SCGC is a premier VC/PE fund in China and a pioneer of the Government Sponsored Fund (GBF) structure. The firm had grown to RMB 20 billion in just ten years and had funds in 29 different cities across China. As competition for investments becomes more intens...Starting at €8.20
-
Bain Capital: Outback Steakhouse
Gompers, Paul A.; Mugford, Kristin; Kim, J. DanielCase HBS-212087-EFinanceBain Capital had purchased Outback Steakhouse in 2007 and despite the myriad initiatives to improve operations, the financial collapse in 2008 threatened the company's ability to meet its loan covenants. Outback's performance steadily declined throughoutStarting at €8.20
-
Harrah's Entertainment
Gompers, Paul A.; Mugford, Kristin; Kim, J. DanielCase HBS-213054-EFinanceThis case examines the issues of establishing a capital structure for the leveraged buyout of Harrah's Casino.Starting at €8.20
-
Private Equity Exits
Gompers, Paul A.; Dore, TimothyCase HBS-213112-EFinanceThis note presents statistics on private equity exits and discusses important issues relating to the most common exits routes.Starting at €8.20
-
HgCapital and the Visma Transaction (A)
Gompers, Paul A.; Misztal, Karol; Van Gool, JorisCase HBS-214018-EFinanceThis case concerns the negotiations of a deal by HgCapital, a UK-based private equity firm, to buy Visma, ASA, a Norwegian software company. Visma has received an offer from Sage Group, a strategic acquirer. HgCapital must determine if it wants to bid and how to outbid a potential strategic acquirer. The case concerns bidding and negotiations strategies as well as deal structuring issues. In particular, the cross border nature of the investment, ...Starting at €8.20